U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ABREZEKIMAB
INN  
Official Name English
abrezekimab [INN]
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 13) (HUMANIZED MONOCLONAL CDP7766 .GAMMA.1-CHAIN FAB FRAGMENT), DISULFIDE WITH HUMANIZED MONOCLONAL CDP7766 .KAPPA.-CHAIN
Systematic Name English
Code System Code Type Description
NCI_THESAURUS
C167050
Created by admin on Tue Apr 01 22:03:01 GMT 2025 , Edited by admin on Tue Apr 01 22:03:01 GMT 2025
PRIMARY
CAS
2043952-59-4
Created by admin on Tue Apr 01 22:03:01 GMT 2025 , Edited by admin on Tue Apr 01 22:03:01 GMT 2025
PRIMARY
SMS_ID
100000181733
Created by admin on Tue Apr 01 22:03:01 GMT 2025 , Edited by admin on Tue Apr 01 22:03:01 GMT 2025
PRIMARY
INN
10745
Created by admin on Tue Apr 01 22:03:01 GMT 2025 , Edited by admin on Tue Apr 01 22:03:01 GMT 2025
PRIMARY
FDA UNII
7V0TA49ZVC
Created by admin on Tue Apr 01 22:03:01 GMT 2025 , Edited by admin on Tue Apr 01 22:03:01 GMT 2025
PRIMARY
ACTIVE MOIETY
ABREZEKIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966